
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Advertising & Sponsorship
Mayo Clinic Marketplace
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Advertising & Sponsorship
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.
As the toll of the Covid-19 pandemic grows, it is increasingly clear the infection is more than a lung disease. Many patients are developing heart complications, though the reasons are not fully understood.
People with heart disease or a history of stroke are at increased risk of the coronavirus infection, and of suffering more severe symptoms, according to the American Heart Association (AHA).
But those severe infections are not only damaging people’s lungs. Doctors are also seeing injuries to the heart – from heart attack, to inflammation of the heart muscle, to potentially fatal heart arrhythmias.
The precise causes are still being sorted out. And they could be both “direct and indirect”, said Dr Sahil Parikh, a cardiologist at Columbia University Irving Medical Center in New York City.
Indirectly, he explained, the overall stress of being critically ill – with lung disease that is robbing the body of oxygen – can exact a toll on people with existing heart problems.
On top of that, there may be particular effects of Covid-19, according to Dr Robert Bonow, a cardiologist at Northwestern University Feinberg School of Medicine in Chicago.
The coronavirus has proteins that attach to certain receptors in lungs. As it happens, blood vessel cells have those same receptors, Bonow explained. It’s thought that the infection may sometimes directly damage blood vessels, which can cause blood clots that lead to a heart attack.
Another heart complication seen in Covid-19 is myocarditis, an inflammation of the heart muscle.
The cause is unclear, with some researchers speculating the coronavirus may sometimes directly infect the heart. But at this point, Parikh said, actual evidence of that “isn’t great”.
Another possible culprit is the immune system’s response against the virus. When it fires out of control – a severe inflammatory reaction known as a cytokine storm – it can damage organs throughout the body, including the heart.
How common are heart complications?
In a study published last month in JAMA Cardiology, doctors at a hospital in Wuhan, China, reported that “cardiac injury” was common in their experience. Among 416 patients hospitalised for severe COVID-19, about 20% suffered a heart injury. More than half of those patients died.
Heart injury was defined as very high levels of a protein called troponin, which is released into the bloodstream when the heart muscle is damaged.
In the United States, where hospitals are in the midst of the Covid-19 “peak,” it’s not known whether the numbers are similar to the Wuhan study, according to Parikh.
“It’s hard to say what the percentages are,” he said, “but a similar spectrum [of heart complications] is being seen.”
For the most part, the complications have struck people with established heart disease or risk factors for it, such as high blood pressure.
“It’s rare that these patients have no cardiovascular risk factors,” Parikh said.
In New York City, the nation’s pandemic epicentre, another consequence has emerged: A surge in 911 calls for cardiac arrest – a heart arrhythmia that is quickly fatal without emergency treatment.
Last week, the city’s Fire Department said calls for cardiac arrest had shot up: From 20 March to 5 April, the city averaged 195 cardiac arrest calls per day, compared to 65 per day for the same period last year, NBC News reported.
It’s hard to know, Parikh said, how many of those victims had Covid-19. People fearful of hospitals may decide to “tough it out” if they develop the warning signs that can precede cardiac arrest, like shortness of breath, dizziness and heart palpitations.
“People dying of cardiac arrest at home are victims of Covid-19,” Parikh said, “though not necessarily directly.”
It’s critical that no one – especially people with known heart disease – ignore symptoms, said Dr J. Wells Askew, a cardiologist at the Mayo Clinic in Rochester, Minnesota.
That means calling your doctor if you think you have coronavirus symptoms, like fever and coughing, or 911 if you have difficulty breathing or chest pain.
Askew acknowledged that when those patients arrive at the hospital, it can be difficult to know if it’s a heart attack or Covid-19.
Parikh agreed, saying, “A few months ago, we would’ve said if it looks like a duck, then it’s probably a duck.” And that would often mean rushing the patient to the catheterisation lab for an invasive procedure to confirm a heart artery is blocked – and then to clear the blockage.
“Now we’re taking a step back, to evaluate whether this is someone at high risk of Covid-19,” Parikh said.
In general, he noted, New York hospitals are trying to limit invasive procedures to emergency situations, to protect both patients and providers.
There are alternatives, Askew said. Patients’ symptoms and medical history, along with imaging tests like ultrasound, can help doctors figure out whether a heart artery is truly blocked.
Like the pandemic, the understanding of Covid-19’s heart consequences is evolving – with doctors using technology to stay up to date. Parikh said he’s part of a WhatsApp group of about 150 area cardiologists who are continually sharing what they’re learning.
READ | How does a severe coronavirus infection possibly injure the heart?
READ | Why heart patients need to be wary of coronavirus
READ | What do we know about congenital heart disease and coronavirus
Oxford team are hoping to have millions of vaccine doses ready by the end of 2020, but will it work?
Reconstructing how many individuals first settled the many small islands in the Pacific and when they arrived remain important scientific questions, as well as an intriguing ones for understanding human history. Human migrations into the islands of Remote Oceania — from circa 3,000 to 1,200 years ago — mark the last major movement into locations previously uninhabited by humans.
These questions are also crucial as part of scientific efforts to understand the role of early history of Pacific islanders on contemporary public health problems including obesity and associated non-communicable diseases such as hypertension and Type 2 diabetes.
A new study in Proceedings of the National Academy of Sciences analyzed the genomes of 1,197 individuals in Samoa and found that the effective population size of the first Samoans was small — ranging from 700 to 3,400 people during the time period from approximately 3,000 to about 1,000 years ago. Starting about 1,000 years ago, population size rapidly increase to about 10,000 individuals, coinciding with increasing agricultural and socio-political complexity, but also with previously hypothesized contacts with other Oceanic peoples.
This population history scenario for Samoa is consistent with the existing archaeological evidence of few, widely scattered and small-sized settlements in the first 2,000 years after Samoa’s initial settlement. But it contrasts with archaeological population reconstructions of much larger population sizes for adjacent Pacific peoples in Tonga and Fiji during that first 1,500 to 2,000 years after initial discoveries around 3,000 years ago.
The research team’s conclusions could help in understanding health conditions of particular importance to people in Samoa, home to some of the highest rates of obesity, heart disease and diabetes in the world.
“These findings are relevant for our ongoing public health research in Samoan populations because they highlight the importance of population history and size in influencing our ability to identify the effect of novel genetic variations, and their interactions with 21st century environments on population health,” said Stephen McGarvey, study co-author and a professor of epidemiology and of anthropology at Brown University.
McGarvey has studied extensively obesity and diseases that stem from obesity — including diabetes, cardiovascular disease, kidney disease and cancer — in Samoa, which are not only a threat to individual health, but to the nations’ economic and social development.
“Smaller populations and the evolutionary mechanisms resulting from them, including genetic drift from bottlenecks and natural selection from novel challenging environments such as experienced by the first settlers of Samoa, make it easier to detect new gene variants and different frequencies of known variants that affect cardiometabolic disease risk factors now in the 21th century,” he said.
The new study also found that modern Samoans derive largely from the Austronesian lineage, including the aboriginal peoples of Taiwan, Island Southeast Asia, coastal New Guinea and other island groups of Oceania — but share 24% of their ancestry with Papuans, the descendants of the people who settled Papua/New Guinea, an estimate markedly lower than found in neighboring Polynesian groups.
The researchers also found strong evidence of population reduction coincident with outside contact from European-derived groups, presumably from infectious diseases new to Samoan immune systems and societal shocks from such epidemics. The whole genome sequence data from participants’ DNA also enabled findings about some genetic diversification within Samoa that may be reflective of regional and local social processes. The genomic data also showed an increase in population size about 150 years ago.
“These findings indicate that the modern Samoan population is a result of these demographic dynamics from the earliest times 3,000 years ago to the very recent colonial period in the 19th century,” McGarvey said. “Any questions about putative genetic influences and their interactions with modern ways of life must be asked in the context of population history.”
Story Source:
Materials provided by Brown University. Note: Content may be edited for style and length.
A new report published in Science Advances on the emergence of agriculture in highland Papua New Guinea shows advancements often associated with a later Neolithic period occurred about 1000 years’ earlier than previously thought.
University of Otago Archaeology Programme Professor and report co-author Glenn Summerhayes says findings in Emergence of a Neolithic in highland New Guinea by 5000 to 4000 years ago, provide insights into when and how the highlands were first occupied; the role of economic plants in this process; the development of trade routes which led to the translocation of plants and technologies; and an associated record of landscape, environment and climate change through time.
The report details the earliest figurative stone carving and formally manufactured pestles in Oceania, dating to 5050 to 4200 years ago, which were found at a dig site in Waim. Also found were the earliest planilateral axe-adzes uncovered in New Guinea to date, and the first evidence for fibrecraft and interisland obsidian transfer from neighbouring islands over distances of at least 800km.
“The new evidence from Waim fills a critical gap in our understanding of the social changes and technological innovations that have contributed to the developing cultural diversity in New Guinea,” Professor Summerhayes says.
The combination of symbolic social systems, complex technologies, and highland agricultural intensification supports an independent emergence of a Neolithic around 1000 years before the arrival of Neolithic migrants, the Lapita, from Southeast Asia. When considered together with a growing corpus of studies indicating expansion and intensification of agricultural practices, these combined cultural elements represent the development of a regionally distinct Neolithic.
The research establishes dating for other finds at the site, including a fire lighting tool, postholes, and a fibrecraft tool with ochre, possibly used for colouring string fibre.
The report suggests increased population pressure on the uneven distribution of natural resources likely drove this process, which is further inferred by language and genetic divergence.
The project arose out of an Australian Research Council Grant awarded to Dr Judith Field (University of New South Wales) and Professor Summerhayes.
“Former Otago postgraduate student Dr Ben Shaw was employed as postdoctoral fellow to do the “leg work in the field” and Dr Anne Ford (Otago Archaeology Programme) contributed to understandings of the stone tool technologies. As it worked out many of these rich discoveries were made by Dr Shaw. It was one of the best appointments Dr Field and I have ever made. I am proud of our Otago graduates who are some of the best in the world.”
Professor Summerhayes and his team had previously completed a Marsden funded project in the Ivane Valley of Papua, establishing the beginning of human occupation at 50,000 years ago. The results of this work were published in Science in 2010.
“This project is a follow-on where we wanted to construct a chronology of human presence in the Simbai/Kaironk Valley of Papua New Guinea by systematic archaeological survey with subsequent excavation and analysis of a select number of sites.
“This work tracks long-term patterns of settlement history, resource use and trade, and establishes an environmental context for these developments by compiling vegetation histories, with particular attention paid to fire histories, indicators of landscape disturbance and markers of climate variability. This will add to understandings of peoples’ impact on the environment.”
Professor Summerhayes received a Marsden grant in late 2019 for his project “Crossing the divide from Asia to the Pacific: Understanding Austronesian colonisation gateways into the Pacific.” This will involve work in the Ramu Valley, which was once part of an inland sea, and will tie in the developments of Highland New Guinea, with the movements of Austronesian speakers into the Pacific.
Story Source:
Materials provided by University of Otago. Note: Content may be edited for style and length.

I normally review my quarterly goals each morning, which is a good habit for staying focused on them throughout the quarter. One new habit I’ve started is to also review a daily reminders list. This is a list of good practices that I want to refresh in my mind each morning, so I can remember to practice them.
The reminders list is good for habits that are difficult to anchor to just one time of day. This can include mindsets, frames, values, and practices that I may want to embody throughout the day. The list is very flexible though, so I can also use it to remind myself of positive habits and their benefits.
My reminders list is pretty long – too long actually – so I want to cull it down to make it more succinct. I started by making an exhaustive list. I can strip away the less important items that really don’t need a daily reminder. I think it’s good to get the list down to a page or less, so it can be reviewed more quickly.
Here are some ideas for what you could include on a daily reminders list:
One reason my list is so big is that many of my daily reminders don’t need to be daily. It contains many sublists. Some of these could be bumped to a weekly or monthly reminder list instead. I do find that a long list is still better than none at all, even if I just take a couple of minutes to skim through it. But the risk of having too many items is that it could clutter my mind instead of helping me focus on the essentials.
One great use of a daily reminder is to warn yourself about blind spots in your thinking. This can help you remain watchful of known weaknesses and traps you’ve fallen into before. So if you have a tendency to overspend on items you don’t need, you could include a daily remind to be frugal and watch out for unnecessary expenses. However you tend to unbalance your life, you can remind yourself to pay attention to the areas where you tend to under-invest, especially while feeling overly busy.
Daily reminders are especially good for changing long-term health habits. You could have daily reminders for some of these good practices if you’re looking to improve your eating habits, for instance:
Your list doesn’t have to be beautiful, so even a hastily created one that you scribble out in a few minutes could be better than none. The key is to establish the habit of reviewing it daily. I like to review mine each morning while sipping a green smoothie.
For some items it’s fine to just include the what. For others you may want to briefly mention the why as well, so you can link the behavior to the purpose behind it. Reminding yourself of the purpose behind your best practices can help you with consistency.
What are some essentials to include on your list? Where do you lose sight of your best practices? Where do you tend to slip after a while? Where are you struggling to be more consistent? Daily reminders can help with all of these.
Daily reminders also create a sense of accountability. If you’re slacking off on some of your best practices, these reminders will alert that you’re falling short. It doesn’t feel good to be reminded of this, and the daily reminders keep that unpleasant realization right in your face. If you try to justify your sliding, your own purposeful reminders will hold you accountable and encourage you to raise your standards. You’ll have to face the music each time you review your list.
This practice is good for prevention too. It’s harder to slack off on a good habit when you keep reminding yourself of its benefits each day, such as by reminding yourself that exercise boosts your mood, clarity, mental endurance, depth of concentration, creativity, and immunity.
I encourage you to test this habit for yourself. It’s easy to get started. Just make a list. Then you can ask one of your devices to remind you to review it each day. Or you could place a physical copy of your list somewhere conspicuous, like taped to your bathroom mirror, so you’ll automatically see it each day.
The director of an NHS Trust says staff only have enough protective gowns to last them for 24 hours.
The latest number of confirmed cases is 2 605.
There have been 48 deaths recorded so far.
According to latest data from the department of health, there have been 903 recoveries.
READ MORE |All the confirmed cases of coronavirus in SA
Minister of Cooperative Governance and Traditional Affairs Nkosazana Dlamini-Zuma says some of the measures the government has put in place during the lockdown will remain once it is lifted.
The minister was speaking during a media briefing by members of the national command council (NCC) in Pretoria on Thursday.
The NCC is spearheading South Africa’s battle against the novel coronavirus pandemic, which has already claimed the lives of 34 people in the country, while 2 506 have tested positive.
“When we do stop the lockdown, we cannot do it abruptly – that today it’s complete lockdown and tomorrow it’s open completely. We have to phase in, so that there is an orderly move towards normality,” said Dlamini-Zuma.
South Africa has been under lockdown since 26 March.
The lockdown regulations include a travel ban, schools shutting down, and large gatherings and the sale of alcohol prohibited, among others.
“Probably every week we are going to be announcing which areas are going to be opened, incrementally, and the conditions of those openings,” said Dlamini-Zuma.
READ MORE | Lockdown will be phased out gradually – Dlamini-Zuma
The second phase of South Africa’s national Covid-19 lockdown will be under rules only slightly altered from the initial hard lockdown, the government announced on Thursday.
Ministers presented their plans for the new phase, before the publication of updated regulations that will take on the force of law, complete with criminal sanction.
There would be “a few amendments”, co-operative governance and traditional affairs minister Nkosazana Dlamini-Zuma said, but mostly existing regulations will be extended.
Coming weeks may see further relaxations, she said, refusing to speak about specifics beyond “schools might be opening” and “industries may have to come slowly on stream”, as part of an “orderly way of easing the lockdown”.
“Expect almost every week new conditions will be coming.”
READ MORE | Lockdown Phase 2: Here’s what we know about rules and how restrictions will change
Separated or divorced parents, who have shared custody of their child or children, will now have visitation rights if they have a court order or birth certificate, the amended regulations of the nationwide lockdown state.
The regulations were released on Thursday by Cooperative Governance and Traditional Affairs Minister Nkosazana Dlamini-Zuma.
The lockdown, which was initially supposed to end on 16 April, continues to the end of the month after President Cyril Ramaphosa announced an extension.
The regulations state parents sharing responsibilities can share their children provided there is a court order allowing them to do so or where there is an agreement or parenting plan that is registered with a family advocate.
Parents can also use certified copies of birth certificates as proof of a legitimate relationship between themselves.
READ MORE | New regulations restore visitation rights for parents with shared custody
Under new rules announced on Thursday South Africans will be able to call out for emergency repair workers such as electricians and plumbers, for the remainder of the extended lockdown period.
The amended regulations govern the 14-day extended lockdown period announced by President Cyril Ramaphosa last week to curb the spread of the coronavirus.
This lockdown period will end on April 30. Government has said the economy will then be “incrementally” opened up, meaning that some trades and services would remain prohibited for longer than others.
The list of emergency repair providers includes plumbers, electricians, locksmiths, glaziers and roof repairers.
READ MORE | New lockdown rules: You can now call a plumber, electrician or someone to fix your roof
For the latest global data, follow this interactive map from Johns Hopkins University & Medicine.
Late on Thursday night, positive cases worldwide were more than 2.1 million, while deaths were more than 142 000.
The United States has the most cases, with more than 650 000.
Five other countries, Spain, Italy, France, Germany and the United Kingdom, have more than 100 000 cases each.
A 99-year-old British World War II veteran on Thursday completed 100 laps of his garden in a fundraising challenge for healthcare staff that has “captured the heart of the nation”, raising more than £13 million13 million ($16.2 million, 14.9 million euros).
“Incredible and now words fail me,” said Tom Moore, a captain who served in India, after finishing the laps of his 25-metre (82-foot) garden with the help of his walking frame.
Moore initially set himself the goal of raising 1000 for a National Health Service charity in time for his 100th birthday at the end of the month, after receiving treatment for cancer and a broken hip.
But his efforts – a rare bit of good news during the global coronavirus pandemic that has killed almost 13 000 people in Britain alone – have made him a star in his own country and abroad, with the government suggesting honours may be in order.
READ MORE | WWII veteran, 99, raises £13m for UK health workers by doing 100 laps in his garden
While countries across the world enact social distancing measures to curb the spread of the new coronavirus, some countries across Africa are dealing with food shortages impacting their neediest populations, as farmers and aid workers are unable to travel to provide the food, the Associated Press reported.
“Most Africans work in the informal sector and need to go out every day. I think above all of access to food,” World Health Organisation Africa regional chief Matshidiso Moeti told the AP.
According to the AP, lockdowns in 33 countries on the continent prevented farmers from getting their produce to markets and hindered food delivery to rural areas. About 20 % of the continent’s population was already food insecure before the pandemic.
“With lockdowns, border closures and the ability to access food curtailed, the impact of Covid-19 on Africa could be like nothing we have seen before,” Sean Granville-Ross, director for Africa at the aid agency Mercy Corps told the AP.
READ MORE | 3 tons of food were burned in Zimbabwe by police trying to enforce social distancing
The World Health Organization (WHO) recently published a blueprint document that listed 70 vaccine candidates that were leading the way towards a solution to the coronavirus pandemic.
While 67 of those vaccines are still in a pre-clinical phase, three of the vaccines are taking the lead and have now been moved on to clinical trials.
The three developers are:
– A collaboration between CanSino Biologics Incorporated and the Beijing Institute of Technology
– Inovio Pharmaceuticals
– A team effort by Moderna Therapeutics and the National Institute of Allergy and Infectious Diseases (NIAID)
Over the past few weeks, we’ve heard a lot about the drugs hydroxychloroquine and chloroquine which are primarily used to treat malaria and autoimmune diseases. US President Donald Trump, for example, has been pushing for its use and recently called it a ‘game-changer’ in the fight against Covid-19.
We spoke to Associate Professor Sean Wasserman, Infectious Diseases Specialist at Groote Schuur Hospital, University of Cape Town and Professor Wolfgang Preiser, Head of the Division of Medical Virology at the University of Stellenbosch on what the evidence suggests.
Misleading claims that there is good evidence to suggest that hydroxychloroquine and chloroquine can treat Covid-19 have been doing the rounds for some time. But evidence suggests otherwise.
Hydroxychloroquine, which is closely related to chloroquine, was first approved by the US Food and Drug Administration (FDA) in 1955 as a treatment for malaria, and has also been widely used for long-term use in autoimmune diseases, such as lupus and rheumatoid arthritis. There’s plenty of safety data and experience on its use for these indications, explains Professor Wasserman.
READ MORE | Coronavirus | The chloroquine debate: Two experts weigh in
A team of Harvard scientists, who modelled the trajectory of the current coronavirus, came to the conclusion that a once-off lockdown, which many countries around the world are currently experiencing, will not completely eradicate the new coronavirus.
Instead, this team suggested in a study that Covid-19 will become seasonal, and that may require intermittent measures of physical distancing to curtail the spread and take the load off health systems.
The study consists of a computer simulation depicting the possible Covid-19 trajectory, which was published in the journal Science.
Seasonal coronaviruses are not new – a couple of strains are known to cause mild cold symptoms
READ MORE | Physical distancing might need to be practised intermittently until 2022 – study
Around the turn of the century, developing countries, led by African countries, dramatically fought for and won safeguards to promote access to medicines in international trade law. These safeguards are now being heralded by lawmakers around the world as critical legal mechanisms that nations can and must use in the fight against Covid-19.
Maybe the most important of these safeguards is the right to grant compulsory licenses when the public interest requires it. In short, compulsory licenses allow generic companies to manufacture and sell medicines even if the medicine in question is still under patent. It is called “compulsory”, since the license is granted whether or not the patent-holder agrees to it. The patent-holder is paid royalties as compensation.
International trade law determines the standards of patent protection that World Trade Organisation (WTO) member countries are required to provide. The WTO was established in 1995 to govern international trade and settle disputes between countries. In the same year, the Agreement on Trade-Related Aspects of Intellectual Property Rights (commonly known as TRIPS) came into force. South Africa has been a member of the WTO since 1995.
The TRIPS agreement obliges WTO member countries to provide 20 years of monopoly protection on patent claims meeting countries’ patentability criteria (these can differ widely between countries).
READ MORE | Covid-19: Patent victories from HIV fight are now more relevant than ever
HEALTH TIPS (as recommended by the NICD and WHO)
• Maintain physical distancing – stay at least one metre away from somebody who is coughing or sneezing
• Practise frequent hand-washing, especially after direct contact with ill people or their environment
• Avoid touching your eyes, nose and mouth, as your hands touch many surfaces and could potentially transfer the virus
• Practise respiratory hygiene – cover your mouth with your bent elbow or tissue when you cough or sneeze. Remember to dispose the tissue immediately after use.
Months into the pandemic, the World Health Organization (WHO) has published a list of 70 vaccine candidates, with three of those already in the first phases of clinical evaluation.
In one of these efforts, France’s Pasteur Institute is working on making use of a modified measles vaccine to trick the body into producing antibodies against the new coronavirus, according to a report.
The Pasteur Institute is renowned for their fight against infectious diseases, having come up with remedies against a number of diseases, including typhoid fever, tuberculosis, yellow fever and HIV.
According to virologist Frédéric Tangy, nearly all 133 research departments of the institute are actively involved in Covid-19 related research.
Tangy and his team will modify a standard measles vaccine in the hope that it will trigger an immune response against the new coronavirus, similar to the action of the MMR vaccine that is currently used against measles, mumps and rubella.
Benefits of this venture would include the fact that an MMR vaccine is quick and affordable to manufacture, and that a single vaccination can trigger strong and long-lasting immunity.
An MMR vaccine usually works by triggering the body to produce antibodies against measles, mumps and rubella after a live, weakened form of these viruses is injected. The weakened form of these viruses is enough to trigger the immune system to deliver a response, but not strong enough to make you ill.
The same strategy showed promising results when it was used for the institute’s vaccine against Chikugunya, a disease caused by Aedes aegypti mosquitos in South Asia. This current vaccine is now in phase thee of its clinical trial.
If this vaccine candidate tuns out to be promising, the University of Pittsburgh’s Centre for Vaccine Research will partner with the Pasteur Institute to start animal testing.
Vials will then be manufactured for the first phase of a clinical trial, which should be able to take place within a year.
Tangy explained that it is vital to have enough time to test for side-effects, as the wrong immune response can be more dangerous than the virus itself.
READ | The new coronavirus: The urgent, but long race for a vaccine
READ | Another coronavirus vaccine being tested in mice
Image credit: Unsplash

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Advertising & Sponsorship
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.